A bill that would allow CBD derived from hemp to be sold as a dietary supplement was introduced in the House of Representatives last week in a bid to jumpstart an industry hampered by inaction from the U.S. Food and Drug Administration (FDA).
The bipartisan measure, The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 (H.R. 8179), was introduced on Friday by Democratic Rep. Kurt Schrader of Oregon and Rep. Morgan Griffith, a Republican from Virginia.
“Hemp was historically an important crop for Virginia farmers, and dietary supplements made from it do not possess dangerous addictive qualities,” Griffith said in a statement. “Nevertheless, the current state of regulation creates confusion about its legal uses. I joined this bipartisan bill to provide certainty for hemp farmers that their crop may find legal uses.”
Measure Builds On 2018 Farm Bill
If passed, H.R. 8179 would ensure that cannabidiol (CBD) and other non-intoxicating constituents of hemp could be lawfully marketed as a dietary supplement under the Federal Food, Drug, and Cosmetic Act. The bill would also require CBD and other hemp extract products to be manufactured and
Bud Digest[otw_is sidebar=otw-sidebar-8]